Papers/PMID:28260263
Iodine supplementation for women during the preconception, pregnancy and postpartum period.
The Cochrane database of systematic reviews2017The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
iodide — no detected effect on preterm birth incidence
Evidence strength: very limited.FindingNull result“There were no clear differences between groups for hypothyroidism in pregnancy or postpartum (pregnancy: average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low-quality evidence, and postpartum: average RR 0.44; 95% CI 0.06 to 3.42, three trials, 540 women, no statistical heterogeneity, low-quality evidence), preterm birth (average RR 0.71; 95% CI 0.30 to 1.66, two trials, 376 women, statistical heterogeneity, low-quality evidence) or the maternal adverse effects of elevated thyroid peroxidase antibodies (TPO-ab) in pregnancy or postpartum (average RR 0.95; 95% CI 0.44 to 2.07, one trial, 359 women, low-quality evidence, average RR 1.01; 95% CI 0.78 to 1.30, three trials, 397 women, no statistical heterogeneity, low-quality evidence), or hyperthyroidism in pregnancy (average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low-quality evidence).”
Quoted verbatim from Iodine supplementation for women during the preconception, pregnancy and postpartum period.. - Study
- meta-analysis
- Participants
- 376
- Population
- Women supplemented with iodine in the preconception, pregnancy or postpartum period, in trials in mild to moderate iodine deficiency settings; trials pooled injected and oral iodine
Effect 0.71 risk ratio, 95% CI 0.3 to 1.66
Iodine supplementation for women during the preconception, pregnancy and postpartum period.2017PMID:2826026310.1002/14651858.CD011761.pub2Permalink